Join to View Full Profile
385 Prospect AveRoom 306Hackensack, NJ 07602
Dr. Jafarian is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Scott Jafarian is an internal medicine specialist with subspecialty training in endocrinology, based in Hackensack, NJ. He completed his residency in Internal Medicine at JFK Medical Center/Raritan Bay Medical Center from 2022 to 2025 and started fellowship in Endocrinology at Hackensack University Medical Center in 2025. He holds a medical degree from Tehran University of Medical Sciences and has completed post-doctoral fellowships at Vanderbilt University and the FDA. His expertise spans endocrinology and diabetes, biostatistics, pharmacology, and internal medicine. Dr. Jafarian has authored several peer-reviewed publications and has been involved in clinical trials investigating metabolic and cardiovascular conditions.
Education & Training
Hackensack University Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 2024
JFK Medical Center/Raritan Bay Medical CenterResidency, Internal Medicine, 2022 - 2025- FDAPost-Doctoral Fellowship, 2019 - 2021
Vanderbilt UniversityPost-Doctoral Fellowship, 2015 - 2019- Vanderbilt UniversityMSCI, Medicine, Scholarship - full, 2015 - 2017
Tehran University of Medical Sciences School of MedicineClass of 2013
Certifications & Licensure
NJ State Medical License 2025 - 2027
ECFMGECFMG
Clinical Trials
- Resveratrol in Metabolic Syndrome: Effect on Platelet Hyper-reactivity and HDL Lipid Peroxidation Start of enrollment: 2014 May 01
- Mechanism(s) Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 1 Start of enrollment: 2018 Nov 15
Publications & Presentations
PubMed
- 13 citationsAssociation of a glucagon-like peptide-1 receptor gene variant with glucose response to a mixed mealMona Mashayekhi, Jessica R. Wilson, Scott R. Jafarian-Kerman, Hui Nian, Chang Yu
Diabetes, Obesity & Metabolism. 2021-01-01 - 23 citationsHighly Reactive Isolevuglandins Promote Atrial Fibrillation Caused by HypertensionJoseph K. Prinsen, Prince J. Kannankeril, Tatiana N. Sidorova, Liudmila V. Yermalitskaya, Olivier Boutaud
JACC. Basic to Translational Science. 2020-06-01 - 22 citationsDPP (Dipeptidyl Peptidase)-4 Inhibition Potentiates the Vasoconstrictor Response to NPY (Neuropeptide Y) in Humans During Renin-Angiotensin-Aldosterone System Inhibition.Scott A. Hubers, Jessica R. Wilson, Chang Yu, Hui Nian, Eric Grouzmann
Hypertension. 2018-09-01
Committees
- PGY3 member, Hackensack Housestaff wellness subcommittee 2022 - Present
Research History
- Postdoctoral fellowship - Clinical Pharmacology2015 - 2019
Professional Memberships
- Member
- Endocrine SocietyMember
Other Languages
- Farsi, Arabic
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
